ALS News

Uncovering the Benefits of Riluzole for ALS Patients

ALS NEWS - August 01, 2020

Riluzole is the only FDA-approved drug therapy for ALS patients. The American Academy of Neurology recommends that Riluzole should be offered to ... Read More

New Breakthrough in Silencing ALS Gene SOD1

ALS NEWS - July 14, 2020

ALS is generally classified into two categories, familial or hereditary ALS and sporadic or non-hereditary ALS. Those with familial ALS (fALS) have mutations in... Read More

New Cells Discovered to be Involved in ALS

ALS NEWS - July 08, 2020

Brown University researchers identified specific cells (glial cells) within the nervous system cells as a potential source of decay in diseases like ALS. T... Read More

Pimozide May Provide Better Quality of Life for ALS patients

ALS NEWS - June 18, 2020

Pimozide is a drug currently being used to suppress the physical (motor) and vocal (phonic) symptoms of tics when these symptoms interfere with daily life ... Read More

Genetic Mutation Affecting Proteins Could Cause ALS

ALS NEWS - June 14, 2020

  Over 5,000 people are diagnosed with ALS each year in the United States. Amyotrophic Lateral Sclerosis is a disease that attacks the very roots of hum... Read More

It is time to ACT against ALS!

ALS NEWS - June 10, 2020

Two pieces of legislation are making their way through congress that could drastically improve the lives of those with ALS. The first is a bill intended to... Read More

Microorganism Involvement in ALS Progression

ALS NEWS - May 31, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the motor neurons in the central nervous system. For years, researchers have bee... Read More

FDA Approves Masitinib for a Phase 3 ALS Clinical Trial

ALS NEWS - May 30, 2020

AB Science, a clinical stage pharmaceutical company, received clearance on their application to use masitinib in an upcoming 3 phase clinical trial to... Read More

FDA Gives Fast Track Status to New Drug for Potential ALS Treatment

ALS NEWS - May 27, 2020

After much research and several clinical trials on neurodegenerative diseases, good news comes from the FDA as they allow Fast Track Designation in the dev... Read More

Biomarkers in Teeth Associated with ALS

ALS NEWS - May 27, 2020

The mission to find biological markers in connection to ALS, or Amyotrophic Lateral Sclerosis is striving and thriving. A recent study has been conducted in the... Read More

$42 Million Invested in ALS Treatments

ALS NEWS - May 15, 2020

QurAlis, a corporation based in Massachusettes, Boston has invested $42 million toward the research and development of ALS treatments. This is such a ... Read More

ALS and COVID-19 Precautions

ALS NEWS - May 03, 2020

Living with ALS can prompt all sorts of questions regarding COVID-19. What is COVID-19? How do I protect myself? How do I protect my loved ones? ... Read More

Finding Biomarkers in ALS: Creatinine Levels and Oxidative Stress

ALS NEWS - April 28, 2020

The lack of biomarkers, or clinical tests to determine an ALS diagnosis, are a deep frustration for patients and the scientific community alike.  In a... Read More